Semaglutide plus tirzepatide are newly developed peptide therapeutics that have revolutionized the treatment of type 2 diabetes. These medications work by activating the effects of glucagon-like peptide-1 (GLP-1), a https://rajanrruk571826.wikicorrespondence.com/user